Publication: Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis
Loading...
Program
relationships.isAuthorOf
Author
Akarsu, Ozger
Baysal, Orhan
Karadag, Serhat
Gursu, Meltem
Uzun, Sami
Gurdal, Ahmet
Cebeci, Egemen
Sumnu, Abdullah
Behlul, Ahmet
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objective: There is a relationship between inflammation and cardiovascular disease (CVD) in patients with chronic kidney disease. Visfatin is an adipocytokine, which has been shown to be associated with inflammation, endothelial dysfunction, and CVD. Our study aimed to examine the relationship of visfatin with metabolic and echocardiographic parameters in patients on peritoneal dialysis (PD).
Description
Source
Keywords
Keywords
Citation
Akarsu O., Baysal O., Karadag S., Gursu M., Ozkan O., Uzun S., Gurdal A., Cebeci E., Sumnu A., Behlul A., et al., -Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis-, TURKISH JOURNAL OF NEPHROLOGY, cilt.29, ss.297-303, 2020